Advances on Chemical Constituents, Pharmacological Effects and Clinical Applications of Dioscorea Panthaicae Rhizoma

ZHAO Ye; WANG Wei-hao; JING Wen-guang; LIU An

doi:10.13422/j.cnki.syfjx.2014180235

您当前的位置：

首页 >

文章列表页 >

Advances on Chemical Constituents, Pharmacological Effects and Clinical Applications of Dioscorea Panthaicae Rhizoma

更新时间：2024-01-04

- Advances on Chemical Constituents, Pharmacological Effects and Clinical Applications of Dioscorea Panthaicae Rhizoma
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 20, Issue 18, Pages: 235-242(2014)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2014180235
  CLC： R282.71
- Published：2014
- 稿件说明：
移动端阅览
ZHAO Ye, WANG Wei-hao, JING Wen-guang, et al. Advances on Chemical Constituents, Pharmacological Effects and Clinical Applications of Dioscorea Panthaicae Rhizoma[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(18): 235-242.
DOI：

ZHAO Ye, WANG Wei-hao, JING Wen-guang, et al. Advances on Chemical Constituents, Pharmacological Effects and Clinical Applications of Dioscorea Panthaicae Rhizoma[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(18): 235-242. DOI： 10.13422/j.cnki.syfjx.2014180235.

摘要

黄山药为我国特有的薯蓣科薯蓣属植物，是国家级（五类）新药地奥心血康的主要药源，该药于2012年获准荷兰上市。本文通过查阅近15年国内外有关黄山药的研究报道，对黄山药化学成分、药理作用以及临床应用进行了综述。对黄山药化学成分研究以甾体皂苷类成分为主，具有治疗心肌缺血、降血脂和抗肿瘤等作用，且临床上对于心肌缺血的应用得到了广泛关注。目前分离得到的甾体皂苷化合物数目还偏少，且药理活性的研究大都集中在薯蓣皂苷上，据此，对黄山药其余甾体皂苷以及其他种类化学成分的发掘和药理活性研究的深度和广度相对匮乏。所以，对其化学成分及药理活性还有待进一步深入研究，以期更好地开发利用。

Abstract

Objective: Dioscorea Panthaica Rhizoma is the main raw material of Diao Xinxuekang

which was approved to sell as drug in Holland in 2012.In this review

researches of the chemical components of D. panthaica

their pharmacological actions and clinical applications were summarized based on the domestic and abroad literatures in past 15 years. The researches of the chemical constituents in D.panthaica focused on steroid saponins

which had curing myocardial ischemia

hypolipidemic and antitumous effecst

and its treatment of myocardial ischemia had drawn widely attention of medical field. Compounds isolated from this herb were less

and only dioscin underwent further researches of pharmacological activities. While the discoveries of the other steroidal saponins and their chemical constituents as well as their pharmacological actions were very scarce. Thereby further research of D. panthaica is worthwhile to fulfill the use of plant resources.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Research Progress on Seed Oil

Research Progress in Chemical Components, Pharmacological Effectiveness and Toxicity of Radix et Rhizoma Sophorae tonkinensis

Research Progress in Chemical Components, Pharmacological Effectiveness and Toxicity of Ferula assafoetid

Research Progress in Chemical Components,Pharmacological Effectiveness and Toxicity of Radix et Rhizoma Sophorae tonkinensis

Chemical Components and Pharmacological Effect of Hominis Placenta： A Review

Related Author

LIN Hong-ying

WU Jian-mei

ZHANG Wen-sheng

WANG Jun-ming

CUI Ying

ZHAO Bao-sheng

GUI Hai-shui

ZHU Yin-di

Related Institution

Department of Clinical Herbology,School of Pharmacy,Henan University of Traditional Chinese Medicine

School of Basic Medicine， Chengdu University of Traditional Chinese Medicine

Key Laboratory of Modern Preparation of Traditional Chinese Medicine of Ministry of Education， Jiangxi University of Chinese Medicine

Key Laboratory of Natural Medicine Pharmacology of Yunnan Province， School of Pharmacy， Kunming Medical University

School of Pharmacy， Guangxi University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰